0001127602-12-006732.txt : 20120217 0001127602-12-006732.hdr.sgml : 20120217 20120217162935 ACCESSION NUMBER: 0001127602-12-006732 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120214 FILED AS OF DATE: 20120217 DATE AS OF CHANGE: 20120217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLACKSON TIMOTHY P CENTRAL INDEX KEY: 0001242992 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 12623025 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4/A 1 form4a.xml PRIMARY DOCUMENT X0304 4/A 2012-02-14 2012-02-16 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242992 CLACKSON TIMOTHY P C/O ARIAD PHARMACEUTICALS INC 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 President, R&D, CSO Common Stock 2012-02-14 4 M 0 16500 3.90 A 138150 D Common Stock 2012-02-14 4 S 0 16500 15.50 D 121650 D Employee Stock Option (Right to Buy) 3.90 2012-02-14 4 M 0 16500 0 D 2004-08-15 2013-08-15 Common Stock 16500 0 D Shares were acquired upon the exercise of outstanding stock options at $3.90 per share. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-02-17